biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Bioasis Webinar.

<< Previous

Bullboard Posts

Next >>

Comment by Aarcoron Dec 20, 2022 1:47pm

169 Views

Post# 35182669

RE:RE:Bioasis Webinar.

Holy c&@p Sir Holler, you must be stuck holding a large steaming bag at 18 cents from last week. You are rivalling JD for Promoter of the Year, but that's only because he flipped 180 after the lobotomy a few months back. You're obviously the de facto leader heading into 2023 though. Good luck !

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season